Hypoxic drive caused Type 3 neovascularization in a preclinical model of exudative age-related macular degeneration.

Hypoxia associated with the high metabolic demand of rods has been implicated in the pathology of age-related macular degeneration (AMD), the most common cause of adult blindness in the developed world. The majority of AMD-associated severe vision loss cases are due to exudative AMD, characterized by neovascularization. To further investigate the causes and histopathology of exudative AMD, we conditionally induced hypoxia in a novel preclinical AMD model (Pde6gcreERT2/+;Vhl-/-) by targeting Vhl and used multimodal imaging and immunohistochemistry to track the development of hypoxia-induced neovascularization. In addition to developing a preclinical model that phenocopies exudative AMD, our studies revealed that the photoreceptor hypoxic response initiates and drives Type 3 neovascularization, mainly in the outer retina. Activation of the VHL-HIF1a-VEGF-EPO pathway in the adult retina led to long-term neovascularization, retinal hemorrhages, and compromised retinal layers. Our novel preclinical model would accelerate the testing of therapies that use metabolomic approaches to ameliorate AMD.

[1]  S. Tsang,et al.  Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  S. Tsang,et al.  Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa. , 2018, Ophthalmology.

[3]  C. Grimm,et al.  The Role of Hypoxia, Hypoxia-Inducible Factor (HIF), and VEGF in Retinal Angiomatous Proliferation. , 2018, Advances in experimental medicine and biology.

[4]  Michael W. Country,et al.  Retinal metabolism: A comparative look at energetics in the retina , 2017, Brain Research.

[5]  A. Lotery,et al.  The complexities underlying age-related macular degeneration: could amyloid beta play an important role? , 2017, Neural regeneration research.

[6]  S. Tsang,et al.  Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. , 2016, The Journal of clinical investigation.

[7]  Katherine J. Wert,et al.  Neuroretinal hypoxic signaling in a new preclinical murine model for proliferative diabetic retinopathy , 2016, Signal Transduction and Targeted Therapy.

[8]  S. Sivaprasad,et al.  Spare the rods and spoil the retina: revisited , 2016, Eye.

[9]  S. Tsang,et al.  Halting progressive neurodegeneration in advanced retinitis pigmentosa. , 2015, The Journal of clinical investigation.

[10]  S. Tsang,et al.  Rod metabolic demand drives progression in retinopathies , 2015, Taiwan journal of ophthalmology.

[11]  Francesco Bandello,et al.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) , 2014, British Journal of Ophthalmology.

[12]  Joan W. Miller,et al.  Vascular endothelial growth factor a in intraocular vascular disease. , 2013, Ophthalmology.

[13]  M. Pennesi,et al.  Animal models of age related macular degeneration. , 2012, Molecular aspects of medicine.

[14]  S. Tsang,et al.  Mice with a D190N Mutation in the Gene Encoding Rhodopsin: A Model for Human Autosomal-Dominant Retinitis Pigmentosa , 2012, Molecular medicine.

[15]  P. Kaiser,et al.  Neovascular Age-Related Macular Degeneration , 2012, Drugs.

[16]  M. Stewart.  The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. , 2012, Mayo Clinic proceedings.

[17]  B. Feigl.  Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis , 2008, Progress in Retinal and Eye Research.

[18]  P. Kaiser,et al.  Neovascular age-related macular degeneration: potential therapies. , 2008, Drugs.

[19]  J. Flannery,et al.  Very Low Density Lipoprotein Receptor, a Negative Regulator of the wnt Signaling Pathway and Choroidal Neovascularization* , 2007, Journal of Biological Chemistry.

[20]  A. Loewenstein,et al.  Targeting Vascular Endothelial Growth Factor , 2007, Drugs & aging.

[21]  Jay M Stewart,et al.  A new model of experimental subretinal neovascularization in the rabbit. , 2006, Experimental eye research.

[22]  Andreas Wenzel,et al.  In vivo confocal imaging of the retina in animal models using scanning laser ophthalmoscopy , 2005, Vision Research.

[23]  D. Mukhopadhyay,et al.  Role of elongin-binding domain of von hippel lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma , 2005, Oncogene.

[24]  R. Sidman,et al.  Spare the rod and spoil the eye , 2005, British Journal of Ophthalmology.

[25]  J. Block,et al.  Hypoxia induces HIF‐1α and VEGF expression in chondrosarcoma cells and chondrocytes , 2004 .

[26]  N. Bressler.  Age-related macular degeneration is the leading cause of blindness... , 2004, JAMA.

[27]  W. Manning,et al.  AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. , 2003, Investigative ophthalmology & visual science.

[28]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[29]  K. Csaky,et al.  Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. , 2000, Investigative ophthalmology & visual science.

[30]  I J Constable,et al.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. , 2000, The American journal of pathology.

[31]  L. Chan,et al.  Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. , 1999, Atherosclerosis.

[32]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[33]  P. Campochiaro,et al.  Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. , 1998, Investigative ophthalmology & visual science.

[34]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[35]  D. Landau,et al.  Exudative age-related macular degeneration in patients with diabetic retinopathy and its relation to retinal laser photocoagulation , 1997, Eye.